Xcytrin motexafin gadolinium: Interim Phase I data

Interim data from a dose-escalation, U.S. Phase I trial in about 12 evaluable patients receiving Xcytrin in combination with Taxotere docetaxel showed that 6 patients achieved a partial response, inc...